Edition:
India

Lupin Ltd (LUPN.BO)

LUPN.BO on Bombay Stock Exchange

904.90INR
22 Jun 2018
Change (% chg)

Rs6.05 (+0.67%)
Prev Close
Rs898.85
Open
Rs897.00
Day's High
Rs908.60
Day's Low
Rs882.00
Volume
224,695
Avg. Vol
143,663
52-wk High
Rs1,176.00
52-wk Low
Rs723.55

Select another date:

Tue, May 15 2018

Photo

Lupin expects U.S. drug pricing pressure to ease in 2019

India's second-largest drugmaker Lupin Ltd said on Wednesday it expected pressure on drug prices in the United States, which has hit its profits, to ease this year as larger rivals reduce their exposure there.

UPDATE 2-India's Lupin expects U.S. drug pricing pressure to ease in 2019

* U.S. sales fall 21.1 pct; India sales up 14 pct (Adds management comments from conference call)

India's Lupin posts surprise Q4 loss on one-time charge

May 15 Lupin Ltd, India's second-largest drugmaker by revenue, reported a surprise loss in its fiscal fourth quarter on Tuesday, due to a one-time charge.

BRIEF-India's Lupin Posts March Quarter Consol Net Loss

* MARCH QUARTER CONSOL NET LOSS 7.84 BILLION RUPEES VERSUS PROFIT OF 3.80 BILLION RUPEES LAST YEAR

BRIEF-Lupin Launches Corcal Bone And Beauty Supplement

* LAUNCHES CORCAL BONE AND BEAUTY SUPPLEMENT Source text: http://bit.ly/2I8514t Further company coverage:

BRIEF-Lupin Submits New Drug Application For Etanercept Biosimilar In Japan

* SAYS SUBMITS NEW DRUG APPLICATION FOR ETANERCEPT BIOSIMILAR IN JAPAN

BRIEF-India's Lupin Gets FDA Approval For Generic Temovate Ointment, 0.05 Percent

* GETS FDA APPROVAL FOR GENERIC TEMOVATE OINTMENT, 0.05 PERCENT

BRIEF-India's Lupin Gets FDA Nod For Generic Xenazine Tablets, 12.5 Mg And 25 Mg

* SAYS CO RECEIVES FDA APPROVAL FOR GENERIC XENAZINE TABLETS, 12.5 MG AND 25 MG Source text - http://bit.ly/2qUd2T4 Further company coverage:

BRIEF-India's Lupin Gets Tentative U.S. FDA Nod For Generic Androgel, 1.62 Pct

* SAYS CO RECEIVES TENTATIVE FDA APPROVAL FOR GENERIC ANDROGEL, 1.62 PERCENT Source text - https://bit.ly/2HEhHk8 Further company coverage:

Sensex ends higher; Lupin gains

Indian indexes ended slightly higher on Friday, led by gains in stocks such as Lupin Ltd, but broader gains were capped as sentiment was subdued following U.S. President Donald Trump's proposal to impose more tariffs on China.

Select another date: